Canopy Growth Corporation Common Shares (CGC)
CGC trades on Nasdaq in Health Care, Medicinal Chemicals and Botanical Products . Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), period ending 2026-03-31, https://www.sec.gov/Archives/edgar/data/1737927/000119312526270260/0001193125-26-270260-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), period ending 2026-03-31. Converted from CAD at 1.4219 per USD (ECB reference rate).
Profile
| Field | Value |
|---|---|
| Ticker | CGC on Nasdaq |
| Sector | Health Care |
| Industry | Medicinal Chemicals and Botanical Products |
| Country | Canada |
| IPO year | Not reported by the screener |
| SEC CIK | 0001737927 |
| SEC industry code | Medicinal Chemicals & Botanical Products |
| Incorporated in | Z4 |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $200.2M |
| Net income | -$189.0M |
| Operating income | Not in SEC XBRL data |
| Net margin | -94.4% |
| Operating margin | Operating income not reported |
| Revenue growth | No prior-year revenue to compare |
| Cash | Not in SEC XBRL data |
| Total assets | Not in SEC XBRL data |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 1.6× |
Reported in CAD; shown in US dollars.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B3 | 2026-02-13 |
| Latest annual report | 10-K | 2026-06-15 |
| Latest quarterly / interim | 10-Q | 2026-08-07 |
| Latest current report FORM 8-K | 8-K | 2026-08-07 |
| Latest proxy | DEFA14A | 2026-10-06 |
Source: SEC EDGAR submissions feed, 760 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -18.3% |
| 1 month | -22.1% |
| 3 months | -22.7% |
| Year to date | -37.1% |
| 1 year | -47.7% |
| From 52-week high | -62.7% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Medicinal Chemicals and Botanical Products
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| GLAS | Glass House Brands Inc. Subordinate Voting Shares | $3.85 | -5.64% | $338.8M |
| OBIO | Orchestra BioMed Holdings Inc. | $5.72 | -3.21% | $343.8M |
| USNA | USANA Health Sciences Inc. | $15.46 | +3.41% | $285.6M |
| SNDL | SNDL Inc. Common Shares | $1.16 | -0.85% | $285.5M |
| ACB | Aurora Cannabis Inc. Common Shares | $4.29 | -1.38% | $265.8M |
| TLRY | Tilray Brands Inc. Common Stock | $3.27 | -2.68% | $483.3M |
| NAGE | Niagen Bioscience Inc. | $2.58 | -1.90% | $204.1M |
| MDWD | MediWound Ltd. | $12.22 | -2.71% | $157.8M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier